SOPHARMA AD: Current report 84 buy back 30082012 ENG

opublikowano: 2012-08-30 13:45

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current_report_84_buy_back_30082012_ENG.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 84 / 2012
Date of issue: 2012-08-30
Short name of the issuer
SOPHARMA AD
Subject
Current report 84 buy back 30082012 ENG
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
The Board of Directors of SOPHARMA AD (the “Company") hereby informs that from 23 August 2012 up to and including 29 August 2012 the Company bought 10111 own shares representing 0.0077% of the share capital of the Company, at a total value of BGN 24700.46 on the Bulgarian Stock Exchange. The average price per share was BGN 2.44.

The shares have been bought on the basis of the general meeting resolution of 23. June 2010.

The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers.

The total number of own shares after these transactions is 3186059, representing 2.41% of the share capital of the Company.
Annexes
File Description
Current report 84 buy back 30082012 ENG.doc Current report 84 buy back 30082012 ENG.doc Current report 84 buy back 30082012 ENG

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2012-08-30 Ognian Donev Executive Director